Omeprazole Capsule, Delayed Release Pellets
Product Images NDC 51407-814

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Omeprazole (NDC 51407-814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-664-05lb.jpg (51407 664 05lb)

Label for Omeprazole 40 mg delayed-release capsules, USP, containing 500 capsules. It includes dosage strength, NDC code 51407-664-05, and instructions to keep container tightly closed and protect from light and moisture. Manufactured by Towa Pharmaceutical Europe, S.L., marketed by GSMS, Incorporated. The label emphasizes that capsules should be swallowed whole and not opened, chewed, or crushed.*

FDA Label Image

Chemical Structure (Omeprazole 01)

Chemical structure of Omeprazole, showing its molecular arrangement with a benzimidazole ring linked to a substituted pyridine ring, including methoxy and methyl groups, and a sulfoxide functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.